Your Messages Inbox
Your Article Summary
See Latest ArticlesAfinitor recommended for use in the European Union for patients with advanced kidney cancer
Novartis, 06/01/09
Novartis has received a positive opinion from the Committee for Medicinal Products for Human Use supporting European Union approval of Afinitor Tablets for the treatment of patients with advanced renal cell carcinoma.
Related Articles
Trends from 1999 to 2007 in the surgical treatments of kidney cancer in Europe: data from the Veneto Region, Italy
BJU International, 10/14/09
Relevance Score: 68%
Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2
Proceedings of the National Academy of Sciences of the United States of America, 11/11/09
Relevance Score: 67%
In Vivo Imaging of Human Colorectal Cancer Using Radiolabeled Analogs of the Uroguanylin Peptide Hormone
Anticancer Research, 11/10/09
Relevance Score: 67%
Childhood cancer mortality in Europe, 1970–2007
European Journal of Cancer, 10/14/09
Relevance Score: 67%
Renal Metastasis From Primary Colon Cancer on FDG PET-CT
Clinical Nuclear Medicine, 10/06/09
Relevance Score: 67%
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor